NuChem Sciences a CRO specialized in preclinical drug discovery, offering standalone & integrated services. We Transform Ideas Through Science. Since August 2023, NuChem Sciences is now a Sygnature Discovery business.
| Website | http://www.nuchemsciences.com |
| Revenue | $43.3 million |
| Employees | 193 (88 on RocketReach) |
| Founded | 2011 |
| Address | 2350 Rue Cohen, Suite 201, Montreal, Quebec H4R 2N6, CA |
| Industry | Research Services |
| Keywords | Cro Services, Drug Development, Pharmaceutical Research, Biopharmaceutical Services, Integrated Services, Preclinical Research, Drug Discovery Services, Clinical Research Organization, Pharmaceutical Development, Life Sciences, Drug Research, Scientific Research, Research Services, Contract Research, Pharmaceutical Cro, Biotechnology, Discovery Research, Lead Optimization |
| Competitors | Research Pharmaceutical Services, Charles River Laboratories, Catalent Pharma Solutions, Eurofins, Medpace, WuXi AppTec, Evotec, Syngene International Limited, inVentiv Health Commercial, Clinipace Worldwide +39 more (view full list) |
Looking for a particular NuChem Sciences employee's phone or email?
The NuChem Sciences annual revenue was $43.3 million in 2026.
Claudio Sturino is the Senior Director, Head of Chemistry of NuChem Sciences.
88 people are employed at NuChem Sciences.
NuChem Sciences is based in Montreal, Quebec.